BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 29297907)

  • 41. Percutaneous WATCHMAN Left Atrial Appendage Closure for Japanese Patients With Nonvalvular Atrial Fibrillation at Increased Risk of Thromboembolism - First Results From the SALUTE Trial.
    Aonuma K; Yamasaki H; Nakamura M; Ootomo T; Takayama M; Ando K; Hirao K; Morino Y; Hayashida K; Kusano K; Main ML; Saito S
    Circ J; 2018 Nov; 82(12):2946-2953. PubMed ID: 30305484
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology).
    Reddy VY; Möbius-Winkler S; Miller MA; Neuzil P; Schuler G; Wiebe J; Sick P; Sievert H
    J Am Coll Cardiol; 2013 Jun; 61(25):2551-6. PubMed ID: 23583249
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Optimal combination strategy of left atrial appendage closure plus catheter ablation in a single procedure in patients with nonvalvular atrial fibrillation.
    Du X; Chu H; He B; Wang B; Liu J; Feng M; Yu Y; Fu G; Jin H; Gao F; Zhu J; Chen X
    J Cardiovasc Electrophysiol; 2018 Aug; 29(8):1089-1095. PubMed ID: 29727507
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cryoballoon pulmonary vein ablation and left atrial appendage closure combined procedure: A long-term follow-up analysis.
    Fassini G; Gasperetti A; Italiano G; Riva S; Moltrasio M; Dello Russo A; Casella M; Maltagliati A; Tundo F; Majocchi B; Arioli L; Al-Mohani G; Pontone G; Pepi M; Tondo C
    Heart Rhythm; 2019 Sep; 16(9):1320-1326. PubMed ID: 30928784
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term follow-up after left atrial appendage occlusion with comparison of transesophageal echocardiography versus computed tomography to guide medical therapy and data about postclosure cardioversion.
    Berte B; Jost CA; Maurer D; Fäh-Gunz A; Pillois X; Naegeli B; Pfyffer M; Sütsch G; Scharf C
    J Cardiovasc Electrophysiol; 2017 Oct; 28(10):1140-1150. PubMed ID: 28675629
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Electrical isolation of the left atrial appendage by Maze-like catheter substrate modification: A reproducible strategy for pulmonary vein isolation nonresponders?
    Bordignon S; Perrotta L; Dugo D; Bologna F; Nagase T; Fuernkranz A; Chun KRJ; Schmidt B
    J Cardiovasc Electrophysiol; 2017 Sep; 28(9):1006-1014. PubMed ID: 28626989
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early Canadian Multicenter Experience With WATCHMAN for Percutaneous Left Atrial Appendage Closure.
    Saw J; Fahmy P; Azzalini L; Marquis JF; Hibbert B; Morillo C; Carrizo A; Ibrahim R
    J Cardiovasc Electrophysiol; 2017 Apr; 28(4):396-401. PubMed ID: 28128883
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Left Atrial Appendage Management with the Watchman Device during Hybrid Ablation of Atrial Fibrillation.
    Vroomen M; Maesen B; Luermans JG; Crijns HJ; Maessen JG; La Meir M; Pison L
    J Interv Cardiol; 2019; 2019():4525084. PubMed ID: 31772531
    [TBL] [Abstract][Full Text] [Related]  

  • 49. First experience with the Watchman FLX occluder for percutaneous left atrial appendage closure.
    Seeger J; Birkemeyer R; Rottbauer W; Wöhrle J
    Cardiovasc Revasc Med; 2017; 18(7):512-516. PubMed ID: 28495117
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and Safety of the WATCHMAN Left Atrial Appendage System for Stroke Prevention in Chinese Patients with Nonvalvular Atrial Fibrillation: A Single-center, Prospective, Observational Study.
    Huang WP; Zhang YH; He L; Su X; Yang XW; Guo ZX
    Chin Med J (Engl); 2017 Feb; 130(4):434-438. PubMed ID: 28218217
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Subxiphoid Hybrid Epicardial-Endocardial Atrial Fibrillation Ablation and LAA Ligation: Initial Sub-X Hybrid MAZE Registry Results.
    Ellis CR; Badhwar N; Tschopp D; Danter M; Jackson GG; Kerendi F; Walters T; Fang Q; Deuse T; Beygui R; Lee RJ
    JACC Clin Electrophysiol; 2020 Dec; 6(13):1603-1615. PubMed ID: 33334437
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Feasibility and Safety of Left Atrial Appendage Closure Using the LAmbre Device in Patients with Nonvalvular Atrial Fibrillation with or Without Prior Catheter Ablation.
    Feng XF; Zhang PP; Sun J; Wang QS; Li YG
    Int Heart J; 2019 Jan; 60(1):63-70. PubMed ID: 30464131
    [TBL] [Abstract][Full Text] [Related]  

  • 53. One-stop strategy for treatment of atrial fibrillation: feasibility and safety of combining catheter ablation and left atrial appendage closure in a single procedure.
    Chen M; Wang ZQ; Wang QS; Sun J; Zhang PP; Feng XF; Li W; Yu Y; Liu B; Mo BF; Zhang R; Yang M; Gong CQ; Zhao MZ; Yu YC; Zhao Y; Lu QF; Li YG
    Chin Med J (Engl); 2020 Jun; 133(12):1422-1428. PubMed ID: 32433041
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Safety of percutaneous left atrial appendage closure with the Amplatzer cardiac plug in patients with atrial fibrillation and contraindications to anticoagulation.
    Wiebe J; Bertog S; Franke J; Wettstein O; Lehn K; Hofmann I; Vaskelyte L; Sievert H
    Catheter Cardiovasc Interv; 2014 Apr; 83(5):796-802. PubMed ID: 24327462
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thoracoscopic Left Atrial Appendage Clipping: A Multicenter Cohort Analysis.
    van Laar C; Verberkmoes NJ; van Es HW; Lewalter T; Dunnington G; Stark S; Longoria J; Hofman FH; Pierce CM; Kotecha D; van Putte BP
    JACC Clin Electrophysiol; 2018 Jul; 4(7):893-901. PubMed ID: 30025689
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Initial experience with a novel percutaneous left atrial appendage exclusion device in patients with atrial fibrillation, increased stroke risk, and contraindications to anticoagulation.
    Massumi A; Chelu MG; Nazeri A; May SA; Afshar-Kharaghan H; Saeed M; Razavi M; Rasekh A
    Am J Cardiol; 2013 Mar; 111(6):869-73. PubMed ID: 23312129
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Left atrial catheter ablation in patients with previously implanted left atrial appendage closure devices.
    Wintgens LIS; Klaver MN; Swaans MJ; Alipour A; Balt JC; van Dijk VF; Rensing BJWM; Wijffels MCEF; Boersma LVA
    Europace; 2019 Mar; 21(3):428-433. PubMed ID: 30380015
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Application of Mimics three-dimensional imaging in percutaneous left atrial appendage closure with Watchman system].
    Yang D; Xu Z; Zhang Y; Luo Y; Zhang J; Wang Y; Gunalingam B; Zhang X
    Zhonghua Xin Xue Guan Bing Za Zhi; 2015 Apr; 43(4):352-7. PubMed ID: 26082369
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Left atrial appendage volume as a new predictor of atrial fibrillation recurrence after catheter ablation.
    Pinto Teixeira P; Martins Oliveira M; Ramos R; Rio P; Silva Cunha P; Delgado AS; Pimenta R; Cruz Ferreira R
    J Interv Card Electrophysiol; 2017 Aug; 49(2):165-171. PubMed ID: 28567579
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Left atrial appendage closure with Watchman device: Insights from the first-ever Tunisian experience and six-year follow-up.
    Chamtouri I; Jomaa W; Abdallah W; Ben Hamda K; Maatouk F
    Tunis Med; 2021 Mai; 99(5):525-530. PubMed ID: 35244901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.